This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
link] Download Issue PDF Download RIS Articles in this issue Flu Vaccines Are a Go Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. February 25, 2025. Accessed June 30, 2025. Subscribe Now!
The evaluation period of the study began on August 1, 2023, after the CDC’s Advisory Committee on Immunization Practices (ACIP) recommendations were released, and continued through February 28, 2025. News release. News release. Human Vaccines & Immunotherapeutics , 21 (1). RSV in Adults. Updated July 8, 2025. RSV Vaccines.
Gearing Up for Vaccine Season Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. J Am Pharm Assoc (2003). 2022;62(1):305-308. doi:10.1016/j.japh.2021.10.001 Subscribe Now!
link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Pneumococcal 21-Valent Conjugate Vaccine Generates Positive Response in Adults at Increased Risk of Disease. PharmacyTimes. Published October 21, 2024. Accessed August 11, 2025.
In a pressrelease, SamaCare founder and CEO Syam Palkurthy said, “SamaCare's growth is directly tied to real human impact—and that's what truly motivates us. Stock.adobe.com SamaCare announced that it is officially ranked on Inc. ’s s annual 5,000 list.
Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. When you go back and you start looking at how you're changing your practice, that means the conference did what it was supposed to do. Subscribe Now!
2019.04.011 Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Racial disparities in adult pneumococcal vaccination indications and pneumococcal hospitalizations in the US. J Natl Med Assoc. 2019;111(5):540-545. doi:10.1016/j.jnma.2019.04.011
Further, the incidence, severity, and kinetics of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome with CD20 × CD3 TCEs may vary depending on the B-cell lymphoma subtype and the combination partners used, which is a notable consideration for oncology pharmacists when operationalizing these therapies.
link] FTC Releases Second Interim Staff Report on Prescription Drug Middlemen. News release. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Drug Channels. April 9, 2024. Accessed July 23, 2025. Federal Trade Commission.
1 "We’ve established a paradigm for AI-driven drug repositioning," Peng Luo, MD, senior author of the study, said in a news release accompanying the results. News Release. Released July 30, 2025. Accessed August 7, 2025. doi:10.1038/s41401-025-01539-1 2. Far Publishing Limited. EurekAlert! Accessed August 7, 2025.
Expanded warnings include interactions with CNS depressants and rare outcomes like esophageal dysfunction, aligning with CDC's 2022 opioid prescribing guidelines. 3 The guideline presents 12 voluntary, evidence-based suggestions for opioid management.
Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. I'm blown away by how quickly new information is brought to this conference and how well the teams break it into actionable insights you can bring back to your patient care. Subscribe Now!
Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!
Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. We encourage pharmacists to get involved and connect with their state pharmacy association to participate in the advocacy efforts in their state. Subscribe Now!
3,6 To effectively implement these changes, the FDA will collaborate with key stakeholders to develop clear and reproducible guidelines for appropriate use and ensure the rigor and continuity of the standards currently in place for drug development. News release. 3,6 REFERENCES FDA drug approval process infographic (horizontal).
Bridging Gaps in Pharmacy Access Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Medicina (Kaunas). 2019;55(7):327.doi:10.3390/medicina55070327 Subscribe Now!
6 This study adds real-world evidence to guideline-recommended use of GLP-1 receptor agonists for kidney protective effects in DKD. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. REFERENCES Mo Q, Adam TJ, Johnson SG, Moheet A, Pieczkiewicz DS. Diabetes Care. 2008;31(8):1473-1478. Kidney Int.
In a pressrelease, NIH director Jay Bhattacharya said, “By reinstating this Task Force, we are reaffirming our commitment to rigorous science, continuous improvement, and the trust of American families. Billion, Enhancing Respiratory Vaccine Pipeline Why did HHS reinstate the Task Force on Safer Childhood Vaccines?
Subscribe Now! Related Videos Related Content Advertisement June 27th 2025 Chronic IVIG Therapy May Reduce Incidence of Cancer, Especially in Patients With CIDP Luke Halpern, Assistant Editor June 3rd 2025 S2.
News release. link] Download Issue PDF Download RIS Articles in this issue Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season Flu Vaccines Are a Go Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. March 26, 2025.
The study underscores the need for improved adherence to GINA guidelines to reduce exacerbation risks and improve patient outcomes. Pharmacist-led interventions and audits of prescribing practices could enhance guideline implementation and optimize asthma management.
link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Updated June 24, 2025. Accessed June 24, 2025. Subscribe Now!
Long-term data [are] pivotal to this, highlighting the profound impact this innovative treatment can have on atopic dermatitis well into the future,” said Baldo Scassellati Sforzolini, MD, PhD, global head of research and development at Galderma, in a news release. News release. News release. June 6, 2025. Mayo Clinic.
Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. USP plans to continue expanding its advanced technology footprint into an additional 8,000 square foot laboratory in 2026. Learn more about USP’s supply chain solutions. Subscribe Now!
Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!
link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Patient-reported outcomes show improved symptoms with zongertinib for HER2-mutated non-small cell lung cancer. Pharmacy Times. May 30, 2025. Accessed August 8, 2025. Subscribe Now!
In his own community, he found chronic disease management to be a pressing need and designed a telehealth program to meet it. News release. 2018.203609 Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. May 9, 2019. December 2022.
Bridging Gaps in Pharmacy Access Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. PLOS Digit Health. 2022;1(10):e0000104. doi:10.1371/journal.pdig.0000104 Subscribe Now!
1: SGLT2 Inhibitors Are Protective Many guidelines now indicate that SGLT2 inhibitors are a standard of care for cardiovascular, renal, and metabolic protection in individuals with type 2 diabetes (T2D). 2: Start With Metformin, Add an SGLT2 Inhibitor All major guidelines still consider metformin the drug of choice for patients with T2D.
Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. There is a lot of collaboration with the pharmacy on this. Once again, it is benign medicine but can have some side effects as well. Subscribe Now!
Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. You learn what to watch for, how these therapies may be implemented, and how to prepare so we can stay up to date—for both our patients and our institutions. Subscribe Now!
Because Ned Said: New Technology Helps Prevent Opioid Overdose Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. J Am Pharm Assoc (2003). 2022;62(4):1407-1416.doi:10.1016/j.japh.2022.02.005 doi:10.1016/j.japh.2022.02.005 Subscribe Now!
Bridging Gaps in Pharmacy Access Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!
The impact of pharmaceuticals released to the environment. Bridging Gaps in Pharmacy Access Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. REFERENCES 1. United States Environmental Protection Agency. Updated November 14, 2024.
Gabrail et al explained in the poster that new delivery platforms are being explored based on these promising results, including on-body injectors, transdermal patches, and controlled-release oral tablets. These technologies could further simplify administration and expand access to this optimized delivery strategy. Subscribe Now!
Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Presented at: American Association of Pharmacy Technicians 2025 Annual Pharmacy Technician Convention. Denver, CO. Subscribe Now!
The hospital-approved protocol, created in June 2022, granted TOC pharmacists prescribing authority for guideline-directed medical therapy (GDMT), consisting of a 30-day supply of rescue and triple-therapy inhalers, at discharge for patients with AECOPD. 2023;60:469580231218625.doi:10.1177/00469580231218625 Subscribe Now!
Because Ned Said: New Technology Helps Prevent Opioid Overdose Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now! Related Videos Related Content Advertisement June 25th 2025 Is Fluoride Friend or Foe?
According to a news release, 5 times more patients in the dupilumab arm achieved sustained disease remission compared to those on placebo, defined as complete clinical remission with completion of oral corticosteroid taper by week 16 without relapse and no rescue therapy use during the 36-week treatment period. News Release.
3 Image credit: shidlovski | stock.adobe.com Hypertension, according the most recent US guidelines, is diagnosed when systolic blood pressure (sBP) is ≥130 mm Hg or diastolic blood pressure (dBP) is ≥80 mm Hg, based on the average of 2 or more accurate readings taken on ≥2 separate occasions.¹ J Am Coll Cardiol. 2018;71:e127-e248.
4-6 Although CAR T-cell therapies and bispecific antibodies have emerged as second- and third-line treatments, these treatments have significant logistical and toxicity burdens, including cytokine release syndrome and neurotoxicity, making them unsuitable for all patients. News release. J Clin Oncol. 2025;43(9):1061-1072. Pfizer Inc.
link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. August 8, 2024. Accessed July 8, 2025. Multiple myeloma. Cleveland Clinic. May 4, 2022. Accessed July 8, 2025. Subscribe Now!
4 “We are thrilled that the FDA has granted RMAT designation to BEAM-101, following orphan drug designation earlier this year, reinforcing its potential as a 1-time, best-in-class therapy for severe SCD,” Giuseppe Ciaramella, PhD, president of Beam Therapeutics, said in the news release. News release. News release.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content